Latest News
ADARx Pharmaceuticals, Inc.
- ADARx Pharmaceuticals, Inc. Actuals & Estimates (BOATS:ADRX)
- UBS initiates ADARx Pharmaceuticals stock with buy rating on siRNA platform
- Shannon Wellman Appointed Senior Director, Head of Talent at ADARx Pharmaceuticals
- ADARx’s $446m IPO signals investor appetite for next-gen RNA therapeutics
- ADARx Pharmaceuticals, Inc. (ADRX) Share Price, News, Stock Market Cap NASDAQ
- HBM Healthcare Investments Increases Its Stake in Portfolio Company ADARx Pharmaceuticals Through IPO
- ADARx Pharmaceuticals shares soar in Nasdaq debut after upsized IPO
- ADARx Pharmaceuticals Rings the Nasdaq Stock Market Opening Bell
- ADARx scores upsized $446M IPO, while fellow RNA biotech City maps out Nasdaq plans
- Adarx Pharma Climbs 14% After $446.3 Million Upsized IPO
- Updated: ADARx prices $446.3M Nasdaq debut, continuing industry's IPO momentum
- Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO
Headlines from the last 30 days, linking to the original publishers. See all market news →